• Resiniferatoxin (RTX): Precision TRPV1 Inactivation for Oste

  2026-05-31

  Explore how Resiniferatoxin (RTX) delivers ultra-potent, selective and long-lasting relief from osteoarthritis pain by targeting TRPV1 channels. This in-depth analysis reveals the latest clinical insights and protocol considerations for RTX research.

• Cy5 NHS ester(Et): Technical Use Guide for Protein Labeling

  2026-05-30

  Cy5 NHS ester(Et) is a water-soluble, amine-reactive fluorescent dye optimized for labeling primary amines in proteins and biomolecules. It is ideally used in workflows requiring immediate-use fluorescent probes for immunofluorescence, flow cytometry, and fluorescence microscopy. This product should not be used in ethanol-based protocols or for workflows that demand long-term storage of dye solutions.

• ERADECs: Small-Molecule Strategy for Degrading Transmembrane

  2026-05-29

  Song et al. (2026) introduce ERAD-engaging chimeras (ERADECs), a small-molecule technology that repurposes the ER-associated degradation pathway to selectively degrade transmembrane proteins. This approach achieves sub-nanomolar efficacy against targets like PD-L1 and offers new avenues for research on membrane protein modulation.

• Pomalidomide (CC-4047): Applied Workflows in Hematological R

  2026-05-29

  Pomalidomide (CC-4047) empowers hematological malignancy research by enabling precise immunomodulation and robust tumor microenvironment assays. This guide details advanced experimental workflows, protocol enhancements, and troubleshooting strategies that maximize reproducibility and insight across multiple myeloma and erythroid differentiation studies.

• Gastrin I Peptide in Human GI Models: Protocols & Innovation

  2026-05-28

  Harness the precision of human Gastrin I peptide for advanced gastric acid secretion pathway research with hiPSC-derived organoids. This guide delivers actionable protocols, troubleshooting insights, and benchmarks APExBIO's product for reproducibility and translational impact.

• Carfilzomib Enhances 125I Radiation-Induced Cell Death in ES

  2026-05-28

  This study demonstrates that carfilzomib amplifies iodine-125 seed radiation's anti-tumor effects in esophageal squamous cell carcinoma by intensifying endoplasmic reticulum stress. The work elucidates how combined treatment triggers multiple cell death pathways—including apoptosis, paraptosis, and ferroptosis—offering a mechanistically robust approach to overcoming radioresistance.

• UBR1 and UBR2: Central ER Stress Sensors and PQC Regulators

  2026-05-27

  This article examines the recent discovery that the E3 ligases UBR1 and UBR2 function as central ER stress sensors in mammals, revealing a new layer of complexity in protein quality control (PQC). The findings highlight the adaptive stabilization of these N-recognins under ER stress and their role in protecting cells from stress-induced apoptosis, with implications for research on ER stress in cancer and neurodegeneration.

• HyperScribe SP6 High Yield RNA Synthesis Kit: Precision in R

  2026-05-27

  The HyperScribe SP6 High Yield RNA Synthesis Kit empowers researchers to efficiently generate high-yield, modification-ready RNA for advanced applications, including radiolabeled probe synthesis, RNA vaccine research, and RNA interference. Its robust design supports streamlined workflows, exceptional reproducibility, and rapid troubleshooting—making it a standout solution for demanding experimental needs.

• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor An

  2026-05-26

  Wang et al. (2018) systematically delineated the entry mechanism of genotype III grass carp reovirus (GCRV104), demonstrating that viral internalization occurs via clathrin-mediated, pH-dependent endocytosis. Their pharmacological inhibitor profiling clarified the limited role of actin cytoskeleton disruption in GCRV104 entry, informing both virology research and cytoskeletal assay design.

• Capecitabine in Patient-Derived Tumor Models: Precision and

  2026-05-26

  Explore Capecitabine's mechanism and impact in patient-derived assembloid models, revealing how its tumor-selective activation and apoptosis induction via Fas-dependent pathway inform preclinical oncology research and tumor-targeted drug delivery strategies.

• Gastrin I: Precision Tools for Human Gastric Acid Pathway Re

  2026-05-25

  Human Gastrin I peptide from APExBIO unlocks robust, reproducible modeling of gastric acid secretion in advanced in vitro systems—especially hiPSC-derived intestinal organoids. This guide details optimized workflows, troubleshooting strategies, and key innovations driving next-generation gastrointestinal physiology studies.

• Brefeldin A in Cancer and Endothelial Research: Applied Work

  2026-05-25

  Brefeldin A (BFA) redefines ER stress and apoptosis assays by enabling precise dissection of protein trafficking and cell death pathways. This guide delivers actionable workflows, troubleshooting strategies, and translational insights, highlighting APExBIO’s trusted supply and the latest biomarker-informed research.

• HyperScribe™ T7 High Yield RNA Synthesis Kit: Mechanisms & B

  2026-05-24

  The HyperScribe™ T7 High Yield RNA Synthesis Kit enables rapid, high-yield in vitro RNA synthesis using T7 RNA polymerase. This kit supports versatile applications, including capped and biotinylated RNA production for advanced research. Its quantitative performance and workflow integration are supported by published benchmarks and rigorous peer-reviewed evidence.

• Polyether Ionophore Toxicity: Mechanisms and Implications fo

  2026-05-23

  This review provides a comprehensive analysis of the clinical and molecular mechanisms underlying polyether ionophore toxicity in animals, with a focus on Salinomycin and related compounds. The findings highlight the dual significance of these agents—as both toxicants in veterinary contexts and potential anti-cancer candidates—by elucidating their structure, ion transport mechanisms, and cellular effects.

• ERAD-Hijacking ERADECs: A Platform for TM Protein Degradatio

  2026-05-22

  Song et al. introduce ERAD-engaging chimeras (ERADECs), a novel small-molecule platform that co-opts the ER-associated degradation (ERAD) pathway to selectively degrade transmembrane (TM) proteins. This innovation overcomes longstanding barriers in targeted protein degradation, enabling highly efficient elimination of membrane targets and broadening the scope for drug discovery and membrane protein research.

14745 records 1/983 page Next 12345 下5页 Last page